Elevating In-Store AV Design to Resonate with Customers

Whether you’re an integrator, a designer or simply a label-defying creative, the EXPERIENCE is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience traps into the human experience to connect people to place.

 

Retailers have been creating experiences for shoppers for hundreds of years. Those have evolved based on customer needs, technology, and now a pandemic. Experience by Design is peering into the question of retail design adaptation. Host Bryan Meszaros welcomed industry veteran Cindi Kato, VP of Global Retail for CallisonRTKL. Kato has spent over 30 years with the architecture, planning, and design firm, creating successful retail experiences.

Thinking about where retail is right now, Kato said, “They are stepping back and analyzing the business and how it’s changed during the pandemic. Brands are looking more at omnichannel and how all facets can work together.”

Retailers are reconsidering in-store experiences and their message and how it resonates in the world today. Companies are trying new prototypes that allow for adaptions on the interior and exterior, which includes technology. “The technology needs to be purposeful,” Kato added.

Another theme Kato touched on was fulfillment at the store level to meet eCommerce demands. “Retailers are looking at low performing stores or spaces in stores they can adapt to support fulfillment,” she noted.

Fulfillment also means adjusting stores for curbside, pickup, and queues. Kato explained, “Retailers are planning different entryways, one as a pickup and the other to engage. Lines at stores are also an opportunity for engaging at the storefront.”

Engagement and experience are challenging in a touchless world, but Kato discussed that the real connection is in the customer’s hand. “A brand’s app is a big focus right now. That experience should be seamless for customers in the store,” she said.

Join host Bryan Meszaros on Experience by Design every other Wednesday as he explores the latest trends and solutions helping craft the world’s most intriguing experiences.

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More